The effects of bisoprolol, a selective β1-blocker, on glucose metabolism by long-term administration in essential hypertension

Clinical and Experimental Hypertension

Volumn 23, Issue 4, 2001, Pages 305-316

  Owada, A ^a   Suda, S ^a   Hata, T ^a   Miyake, S ^a  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

Author keywords

1 selective blocker; Bisoprolol; Blood glucose; Glucose tolerance test

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; MALE; PULSE RATE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN; MALE; MIDDLE AGED; PULSE; TIME FACTORS;

EID: 0035023490     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-100102669     Document Type: Article

References (24)

1. Use of propranolol (Inderal) in treatment of hypertension
2. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNCV)
3. The management of raised Blood pressure in New zealand: A discussion document
4. Report of Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension
5. The coronary artery disease paradox. The role of hyperinsulinemia and insulin resistance and implications for therapy
6. Diabetes mellitus in treated hypertension: Incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in Primary Prevention Trial Goteborg, Sweden
7. Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients
8. Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients
9. Effects of antihypertensive treatment with β-blockers on glucose metabolism
10. 1 in noninsulin-dependent diabetics
11. Insulin resistance in essential hypertension
12. Characterization of (±) (3H)-carazolol binding to β-adrenoceptors. Application to study of β-adrenergic receptor subtypes in canine ventricular myocardium and lung
13. βadrenoceptor antagonists (non-selective as well as β1-selective) with partial agonistic activity decrease β2-adrenoceptor density in human lymphocytes. Evidence for a β2-agonistic component of partial Agonistic activity
14. Affinity and electivity of β-adrenoceptor antagonists in vitro
15. Nifedipine vs. enalapril In treatment of hypertensive patients with glucose intolerance
16. Effects of antihypertensive therapy on glucose tolerance: Focus on calcium antagonists
17. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: A double-blind, cross-over study
18. Influence of diuretics, calcium antagonists, and α-blockers on insulin sensitivity and glucose tolerance in hypertensive patients
19. 2+ channel antagonists, and α-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension
20. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus
21. The cardioselectivity of beta adrenoceptor antagonist
22. Bisoprolol in angina pectoris
23. Influence of heart rate on mortality among persons with hypertension: The framingham study
24. Beta 1 selectivity, antihypertensive effect and the frequency of stroke